Outcomes of de novo belatacept‐based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization-Reference-Cited by-同舟云学术

Outcomes of de novo belatacept‐based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization

Published:2022-09-11 Issue:11 Volume:27 Page:901-905
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Patel Ankita¹^ORCID,Shertel Tara²,Wynd Michael²,Wadhera Vikram³,Serur David¹,Schleich Benjamin⁴,Yushkov Yuriy³,Goldstein Michael³

Affiliation:

1. Nephrology Hackensack University Medical Center Hackensack New Jersey USA

2. Pharmacy Hackensack University Medical Center Hackensack New Jersey USA

3. Surgery Hackensack University Medical Center Hackensack New Jersey USA

4. Quality Hackensack University Medical Center Hackensack New Jersey USA

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nep.14106

Reference20 articles.

1. Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant

3. OPTN/SRTR 2018 Annual Data Report: Kidney;Hart A;Am J Transplant,2019

4. A Risk Index for Living Donor Kidney Transplantation

5. KDPI score is a strong predictor of future graft function: Moderate KDPI (35 – 85) and high KDPI (> 85) grafts yield similar graft function and survival

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of suboptimal donor to suboptimal recipient kidney transplant on delayed graft function and outcome;Frontiers in Transplantation;2023-09-12

2. Impact of marginal donor to marginal recipient kidney transplant on delayed graft function and outcome;2023-03-29

3. The role of calcium and CaMKII in sleep;Frontiers in Systems Neuroscience;2022-12-22

4. Outcomes of de novo belatacept‐based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization;Nephrology;2022-10-17